Sumner Michael John — SEC Form 4 filings
SEC reporting owner CIK 1936799. 13 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-28 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | 13 | — | — | 37 |
Form 4 filings — Sumner Michael John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 9,450 · Tax withholding (F): 2,693 @ $1.23 · Option exercise (M): 9,450 (derivative) @ $0 · Grant/award (A): 46,876 (derivative) @ $0 · Grant/award (A): 37,684 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,385 · Tax withholding (F): 680 @ $1.30 · Option exercise (M): 2,385 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 4,292 · Tax withholding (F): 1,223 @ $1.74 · Option exercise (M): 4,292 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 36,832 (derivative) @ $0 · Grant/award (A): 29,608 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,010 · Option exercise (M): 11,550 · Tax withholding (F): 3,903 @ $1.79 · Option exercise (M): 5,010 (derivative) @ $0 · Option exercise (M): 11,550 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,916 · Option exercise (M): 2,916 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 28,350 (derivative) @ $0 · Grant/award (A): 35,100 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,385 · Tax withholding (F): 680 @ $1.95 · Option exercise (M): 2,385 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,010 · Option exercise (M): 5,010 (derivative) @ $0 · Grant/award (A): 42,900 (derivative) @ $0 · Grant/award (A): 34,650 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 5,708 (derivative) @ $0 · Grant/award (A): 4,292 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,917 · Option exercise (M): 2,917 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,386 · Option exercise (M): 2,386 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 18,750 (derivative) @ $0 · Grant/award (A): 15,029 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1936799 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →